Athira Pharma Inc (ATHA)
1.985
-0.04
(-1.73%)
USD |
NASDAQ |
May 02, 15:01
Athira Pharma Market Cap: 76.08M for May 2, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 01, 2024 | 77.42M |
| April 30, 2024 | 75.50M |
| April 29, 2024 | 75.50M |
| April 26, 2024 | 73.59M |
| April 25, 2024 | 73.59M |
| April 24, 2024 | 77.04M |
| April 23, 2024 | 78.19M |
| April 22, 2024 | 80.10M |
| April 19, 2024 | 81.64M |
| April 18, 2024 | 78.95M |
| April 17, 2024 | 80.87M |
| April 16, 2024 | 80.87M |
| April 15, 2024 | 78.95M |
| April 12, 2024 | 93.52M |
| April 11, 2024 | 101.57M |
| April 10, 2024 | 95.05M |
| April 09, 2024 | 96.58M |
| April 08, 2024 | 92.75M |
| April 05, 2024 | 94.67M |
| April 04, 2024 | 95.82M |
| April 03, 2024 | 95.82M |
| April 02, 2024 | 95.05M |
| April 01, 2024 | 96.20M |
| March 28, 2024 | 105.02M |
| March 27, 2024 | 98.12M |
| Date | Value |
|---|---|
| March 26, 2024 | 99.27M |
| March 25, 2024 | 97.35M |
| March 22, 2024 | 97.73M |
| March 21, 2024 | 96.58M |
| March 20, 2024 | 94.09M |
| March 19, 2024 | 85.85M |
| March 18, 2024 | 95.43M |
| March 15, 2024 | 100.42M |
| March 14, 2024 | 98.50M |
| March 13, 2024 | 100.42M |
| March 12, 2024 | 96.58M |
| March 11, 2024 | 111.53M |
| March 08, 2024 | 137.21M |
| March 07, 2024 | 159.06M |
| March 06, 2024 | 149.47M |
| March 05, 2024 | 151.77M |
| March 04, 2024 | 156.76M |
| March 01, 2024 | 151.01M |
| February 29, 2024 | 147.56M |
| February 28, 2024 | 152.16M |
| February 27, 2024 | 153.69M |
| February 26, 2024 | 149.86M |
| February 23, 2024 | 150.62M |
| February 22, 2024 | 150.62M |
| February 21, 2024 | 141.81M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
52.90M
Minimum
Nov 09 2023
1.114B
Maximum
Dec 23 2020
321.11M
Average
149.86M
Median
Feb 26 2024
Market Cap Benchmarks
| Xeris Biopharma Holdings Inc | 277.23M |
| Kodiak Sciences Inc | 191.49M |
| Phathom Pharmaceuticals Inc | 564.17M |
| Arcutis Biotherapeutics Inc | 1.000B |
| Inozyme Pharma Inc | 288.25M |
Market Cap Related Metrics
| Price to Book Value | 0.5844 |
| Price | 1.985 |
| Earnings Yield | -155.7% |